Publisher
Springer Science and Business Media LLC
Subject
Genetics,Molecular Biology,General Medicine
Reference39 articles.
1. BenAyed-Guerfali D, Kifagi C, BenKridis-Rejeb W et al (2022) The identification by exome sequencing of candidate genes in BRCA-negative Tunisian patients at a high risk of hereditary breast/ovarian cancer. Genes (Basel) 13(8):1296. https://doi.org/10.3390/genes13081296
2. Frey MK, Kopparam RV, Ni Zhou Z et al (2019) Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center. Cancer 125(5):690–697
3. Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [Updated 2022 May 26]. In Adam MP, Mirzaa GM, Pagon RA, et al (eds) GeneReviews® [Internet]. University of Washington, Seattle; 1993–2022.
4. Gifoni ACLVC, Gifoni MAC, Wotroba CM et al (2022) Hereditary Breast Cancer in the Brazilian State of Ceará (The CHANCE Cohort): higher-than-expected prevalence of recurrent germline pathogenic variants. Front Oncol 12:932957. https://doi.org/10.3389/fonc.2022.932957
5. Rempel E, Kluck K, Beck S et al (2022) Pan-cancer analysis of genomic scar patterns caused by homologous repair deficiency (HRD). NPJ Precis Oncol 6:36. https://doi.org/10.1038/s41698-022-00276-6